This inventor holds 3 USPTO granted patents. Top assignees: Institut Pasteur, Aventis Pharma S.a.. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2002
Title: Innovator Jean-Michel Heard: Pioneering Therapeutic Solutions
Introduction
Jean-Michel Heard, a distinguished inventor based in Paris, France, has made significant contributions to the field of biotechnology. With a portfolio of three patents, his work focuses primarily on developing innovative therapeutic products that leverage advanced cellular technologies.
Latest Patents
Among his latest innovations is a patent for a **Composition for the in vivo production of therapeutic products**. This invention involves cell compositions intended for in vivo implantation, designed for the sustained and controlled delivery of therapeutic substances. Another notable patent is related to a **Recombinant retroviral vector**, which describes an implant created by assembling various in vitro elements to form a neo-organ. This implant is preferentially introduced into the recipient's peritoneal cavity and includes a biocompatible support for biological anchoring of cells that express and secrete compounds of therapeutic interest. The patent also outlines a kit for implant preparation and introduces a new recombinant retroviral vector, featuring modified provirus DNA for enhanced replication.
Career Highlights
Jean-Michel Heard's career is marked by his tenure at renowned institutions such as **Institut Pasteur** and **Aventis Pharma S.A.**. His extensive experience in these respected organizations has allowed him to refine his expertise in biotechnology and foster a deeper understanding of therapeutic product development.
Collaborations
Throughout his career, Heard has collaborated with notable colleagues, including **Philippe Moullier** and **Olivier Danos**. These partnerships have played a crucial role in accelerating research and facilitating significant advancements in their shared field of expertise.
Conclusion
In summary, Jean-Michel Heard stands out as a prominent inventor in the biotechnology landscape. His latest patents showcase his commitment to innovation and therapeutic solutions, and his collaborations highlight the importance of teamwork in achieving impactful scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

